| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $28.06 ▼ -0.80% | Yesterday | $28.37 ▲ +0.33% | Tomorrow's Immunovant Inc. Common Stock (IMVT) setup is anchored to $28.28 and targets $28.06 (-0.80%). The near-term read is downside; watch $29.13 / $27.43 because daily realized volatility is about 4.10%. |
Tomorrow's Immunovant Inc. Common Stock (IMVT) setup is anchored to $28.28 and targets $28.06 (-0.80%). The near-term read is downside; watch $29.13 / $27.43 because daily realized volatility is about 4.10%. | ||||
| Week | $27.58 ▼ -2.48% | Last Week | $28.57 ▲ +1.04% | The 7-day Immunovant Inc. Common Stock model moves from $28.57 to $27.58 (-2.48%). It gives downside momentum context for this stock, so breaks around $29.13 / $27.43 matter more than a single tick. |
The 7-day Immunovant Inc. Common Stock model moves from $28.57 to $27.58 (-2.48%). It gives downside momentum context for this stock, so breaks around $29.13 / $27.43 matter more than a single tick. | ||||
| Month | $26.79 ▼ -5.27% | Last Month | $28.91 ▲ +2.21% | The 1-month Immunovant Inc. Common Stock target is $26.79 (-5.27%), compared with the live reference near $28.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Immunovant Inc. Common Stock target is $26.79 (-5.27%), compared with the live reference near $28.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $25.60 ▼ -9.46% | Last Year | $29.40 ▲ +3.97% | The 1-year Immunovant Inc. Common Stock scenario points to $25.60 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Immunovant Inc. Common Stock scenario points to $25.60 (-9.46%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $22.83 ▼ -19.29% | 5 Years Ago | $30.57 ▲ +8.10% | The 5-year Immunovant Inc. Common Stock view is $22.83 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Immunovant Inc. Common Stock view is $22.83 (-19.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $28.28 | Mid |
| Daily Change | -0.88% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 59% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $28.28 | Daily Change | -0.88% |
| Market Cap | $5.76B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.